NAC and Glutathione: The Master Antioxidant System
Glutathione is the antioxidant your cells actually run on, and it falls with age. The interesting part isn't whether to raise it — it's that the trials with the best results didn't use glutathione, or even NAC alone.
Evidence strength
Level 1b
Individual RCT
Peer-reviewed refs
9
Reading time
10 min
Key Takeaways
- Glutathione synthesis is rate-limited by cysteine. NAC is the practical cysteine donor — which is why NAC raises glutathione and why it is the hospital antidote for paracetamol overdose.
- The strongest human results came from GlyNAC — glycine plus NAC together. Glutathione is a tripeptide, and older adults are typically short of two precursors, not one.
- Oral glutathione does work: a six-month RCT raised body stores at 250 and 1000 mg/day. But precursor loading has better downstream outcome data and costs less.
- NAC's non-liver claims are weaker than its reputation. The psychiatric meta-analysis shows heterogeneous, modest effects — signal worth researching, not a treatment.
Almost every antioxidant you can buy is a bit player. Glutathione is not. It is the tripeptide your cells synthesise for themselves, keep in millimolar concentrations, and use for everything from neutralising peroxides to tagging toxins for excretion. When people talk about "the master antioxidant," this is the one thing in the category that earns the title.
It also declines with age, and low glutathione tracks with oxidative stress and mitochondrial dysfunction across a large gerontology literature. [8] So the obvious question is how to raise it. The answer turns out to be more specific — and more interesting — than "take a glutathione supplement."
Why Cysteine Is the Bottleneck
Glutathione is built from three amino acids: cysteine, glycine, and glutamate. Two of them are abundant. Cysteine is not, and its availability is what limits how much glutathione a cell can make.
This is why NAC exists as an intervention at all. N-acetylcysteine is an acetylated, stable form of cysteine that survives digestion and delivers the missing ingredient. Remove the bottleneck and synthesis rises.
The most vivid demonstration is clinical rather than nutritional. In paracetamol overdose, a toxic metabolite consumes hepatic glutathione until the liver has none left to neutralise it — and then the liver dies. Acetylcysteine, given early enough, refills the tank and prevents that. A Cochrane review confirms it as the established treatment. [5] That is about as clean a proof of the mechanism as medicine offers.
The Result That Should Change Your Stack
Here is the finding most NAC discussions miss. When researchers looked at why older adults are glutathione-deficient, they found deficits in both cysteine and glycine — and correcting both restored glutathione synthesis to youthful rates. [1]
That observation became a research programme. A pilot trial of glycine plus NAC — GlyNAC — in older adults reported improvements across glutathione status, oxidative stress, mitochondrial function, inflammation, insulin resistance, muscle strength, and cognition. [2] A subsequent randomised clinical trial found the same pattern on glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and multiple aging hallmarks. [3]
These are not enormous trials, and enthusiasm should scale accordingly. But the practical implication is sharp: the evidence supports the pair, not the single ingredient. Most people taking NAC for glutathione are supplying one of two missing precursors and calling it done. Glycine is cheap, well tolerated, and doubles as a sleep aid — there is very little reason to leave it out.
Does Swallowing Glutathione Work?
The old dismissal was that oral glutathione gets digested into its constituent amino acids and never arrives intact. That turned out to be too confident. A six-month randomised controlled trial found oral glutathione raised body stores — in blood, erythrocytes, and buccal cells — at both 250 and 1000 mg/day. [4]
So glutathione supplements are not inert. The question is whether they are the best use of the money. The trials that produced meaningful downstream outcomes used precursors, not the intact molecule, and precursor loading costs a fraction as much. Liposomal formulations improve uptake and are the sensible choice if you want the finished product, but they do not change that comparison.
Where NAC's Reputation Runs Ahead of Its Evidence
NAC is sold for a longer list of conditions than its data support, and being honest about that is the point of an evidence-graded site.
Respiratory: solid. The PANTHEON trial randomised over a thousand COPD patients to 600 mg twice daily and found fewer exacerbations. [6] This is NAC's oldest legitimate non-emergency use.
Psychiatric: mixed. A systematic review and meta-analysis across major mental disorders found effects that were modest and heterogeneous — enough to justify ongoing research, not enough to call NAC a treatment. [7] The gap between that conclusion and how NAC is marketed for mood and compulsive behaviour is wide.
Fatty liver: promising, unfinished. Transcriptomic and meta-analytic work points to therapeutic effects in NAFLD, [9] but hard human outcome data lag well behind the mechanistic story.
What to Actually Do
| Goal | Approach |
|---|---|
| Raise glutathione | NAC 1200 mg + glycine 3–5 g daily — the GlyNAC pattern |
| Prefer the finished molecule | Liposomal glutathione 500 mg daily |
| Liver support specifically | Add TUDCA and milk thistle — different mechanisms, not more of the same |
| Timing | NAC morning on an empty stomach; glycine at night |
Expect gastrointestinal grumbling from NAC — nausea and sulphurous burps are dose-related and usually solved by splitting the dose or taking it with food. The anaphylactoid reactions in the literature come from intravenous infusion in overdose care, not capsules.
The One-Line Version
Glutathione is worth raising, cysteine is what limits it, and NAC plus glycine is the combination the trials actually tested. Taking NAC alone is doing three-quarters of a good idea, and taking glutathione itself is doing a more expensive version of the same job. The full stack, including where bile acids and silymarin fit, is laid out in the liver protocol.
Related Reading
Scientific References
- [1]Sekhar RV, Patel SG, Guthikonda AP, et al.. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation — American Journal of Clinical Nutrition (2011)Oxford 2bPMID 21795440
- [2]Kumar P, Liu C, Hsu JW, et al.. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial — Clinical and Translational Medicine (2021)Oxford 2bPMID 33783984
- [3]Kumar P, Liu C, Suliburk J, et al.. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial — Journals of Gerontology Series A (2023)Oxford 1bPMID 35975308
- [4]Richie JP Jr, Nichenametla S, Neidig W, et al.. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione — European Journal of Nutrition (2015)Oxford 1bPMID 24791752
- [5]Chiew AL, Gluud C, Brok J, et al.. Interventions for paracetamol (acetaminophen) overdose — Cochrane Database of Systematic Reviews (2018)Oxford 1aPMID 29473717
- [6]Zheng JP, Wen FQ, Bai CX, et al.. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial — Lancet Respiratory Medicine (2014)Oxford 1bPMID 24621680
- [7]Zheng W, Zhang QE, Cai DB, et al.. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials — Acta Psychiatrica Scandinavica (2018)Oxford 1aPMID 29457216
- [8]Lapenna D. Glutathione and glutathione-dependent enzymes: From biochemistry to gerontology and successful aging — Ageing Research Reviews (2023)Oxford 5PMID 37683986
- [9]Yang K, Kim HH, Shim YR, et al.. Comprehensive transcriptomic analysis and meta-analysis identify therapeutic effects of N-acetylcysteine in nonalcoholic fatty liver disease — Frontiers in Pharmacology (2023)Oxford 2aPMID 37256235
Related protocols
Partner with BiohackingHub
Editorial placements, sponsorships, and product features for evidence-minded brands.